BioSpace News Archive

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that Angela Thedinga has been promoted to chief technology officer.

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, today announced that Sean McCarthy, D.Phil., president, chief executive officer and chairman, will participate at Cowen and Company’s 40th Annual Health Care Conference in Boston, Massachusetts.

Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer, today announced that management will present at the Cowen 40th Annual Health Care Conference in Boston, Massachusetts on Wednesday, March 4, 2020 at 10:00am Eastern Time.

MannKind Corporation reported financial results for the fourth quarter and full year ended December 31, 2019.

United Imaging donates medical equipment worth $14M to help fight coronavirus outbreak

EmCyte, the world leader in platelet rich plasma and progenitor stem cell biologics, announces its FDA 510(k) clearance for its PurePRP® Supraphysiologic Concentrating System for platelet rich plasma.

Heska Corporation, a provider of advanced veterinary diagnostic and specialty products, reported financial results for its fourth quarter and full year ended December 31, 2019.

HCSC Recognized for Cultivating Ethical & Compliant Workforce, Including Training Managers to Handle Employee Concerns Ethically

Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc.

New version supports interoperability standards and runs on Chrome